All In MedTech

FDA Clearance Tracker · P070014-S065

LifeStent Vascular Stent System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 27, 2023 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P070014-S065
Device name
LifeStent Vascular Stent System
Applicant location
Tempe, AZ
Received
Feb 21, 2023
Decided
Jul 27, 2023
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P070014

Device type

Device class
Class III

Every decision under product code NIP

FDA's approval statement

As written in FDA's record.

Approval to update the labeling to include clinical results from the LifeStent Vascular Stent Systems post-approval study (Popliteal Indication)

Source documents

Other decisions for Bard Peripheral Vascular, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.